ニードルフリーインジェクションシステムの世界市場：製品別、技術別、投与部位別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

世界のニードルフリーインジェクションシステムの市場規模は、予測期間の2024年～2031年のCAGRが15.1％となり、2023年の1億5,086万米ドルから2031年には4億6,470万米ドルに成長すると予測されています。世界のニードルフリーインジェクションシステムは、自己投与に対する患者の嗜好の高まり、入院率の上昇、従来の注射針と比較してニードルフリーインジェクションシステムが提供する臨床的利点、技術の進歩、慢性疾患の有病率の上昇、患者の安全性と快適性の重視の高まりなどの要因によって牽引されています。無針注射器は、ジェット注射器としても知られ、針を必要とせず、高圧の流体ストリームを使用して皮膚から薬剤を送達する医療機器です。ニードルフリーインジェクションシステム開発の主な目的は、針刺し損傷、二次汚染、針の再使用を減らすことでした。無針注射器は年々進化しており、ポリオワクチンの供給不足に対処するために世界保健機関（WHO）が推奨しています。無針注射器は、インスリン、ホルモン、ビタミンB-12、その他の液体注射グレードの薬剤を自己投与するための個人使用に理想的です。

マイクロニードルは、薬物の分解を引き起こすことなく、人体や皮膚に効果的に入ることができるため、ますます人気が高まっています。操作しやすいマイクロスケールのフォームファクターと痛みのないドラッグデリバリーは、一般人口の間での需要を促進するさらなる要因です。

糖尿病やその他の感染症の有病率の上昇が、世界のニードルフリーインジェクションシステム市場を大きく牽引しています。糖尿病や感染症の有病率の上昇により、効果的で患者に優しいドラッグデリバリーやワクチンデリバリー方法のニーズが高まっています。感染症に伴う不快感を軽減することで、無針注射器は、治療プロトコルの患者のアドヒアランスを高める説得力のある代替手段を提示します。糖尿病や自己免疫疾患のような慢性疾患の増加により、無針注射はますます普及しており、無針注射は苦痛のない選択肢となっています。さらに、針を使用した注射による感染リスクの増加により、針を使用しない技術やソリューションの重要性がより広く認識されるようになっています。

当レポートでは、世界のニードルフリーインジェクションシステム市場について調査し、市場の概要とともに、製品別、技術別、投与部位別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のニードルフリーインジェクションシステム市場の見通し、2017年～2031年

• 市場規模と予測
• 製品別
• 技術別
• 投与部位別
• 用途別
• エンドユーザー別
• 地域別
• 企業別市場シェア（％）、2023年

第5章 世界のニードルフリーインジェクションシステム市場の見通し、地域別、2017年～2031年

• 北米
• 欧州
• アジア太平洋
• 南米
• 中東・アフリカ

第6章 2023年の市場マッピング

第7章 マクロ環境と産業構造

• 需要供給分析
• 輸出入分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

• Pharmajet Inc
• Crossject SA
• Medical International Technology Inc
• Micropoint Technologies Pte Ltd
• Antres Pharma Inc
• Penjet Corporation
• NuGen Medical Devices Inc
• Ferring International Center SA
• Portal Instruments Inc
• Bioject Medical Technologies Inc

第14章 戦略的提言

第15章 お問い合わせと免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1.Global Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 2.Global Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 3.Global Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 4.Global Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 5.Global Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 6.Global Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 7.Global Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 8.Global Needle Free Injections System Market Share (%), By Region, 2017-2031F
• Figure 9.North America Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 10.North America Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 11.North America Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 12.North America Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 13.North America Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 14.North America Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 15.North America Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 16.North America Needle Free Injections System Market Share (%), By Country, 2017-2031F
• Figure 17.United States Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 18.United States Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 19.United States Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 20.United States Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 21.United States Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 22.United States Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 23.United States Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 24.Canada Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 25.Canada Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 26.Canada Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 27.Canada Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 28.Canada Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 29.Canada Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 30.Canada Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 31.Mexico Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 32.Mexico Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 33.Mexico Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 34.Mexico Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 35.Mexico Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 36.Mexico Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 37.Mexico Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 38.Europe Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 39.Europe Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 40.Europe Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 41.Europe Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 42.Europe Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 43.Europe Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 44.Europe Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 45.Europe Needle Free Injections System Market Share (%), By Country, 2017-2031F
• Figure 46.Germany Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 47.Germany Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 48.Germany Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 49.Germany Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 50.Germany Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 51.Germany Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 52.Germany Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 53.France Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 54.France Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 55.France Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 56.France Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 57.France Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 58.France Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 59.France Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 60.Italy Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 61.Italy Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 62.Italy Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 63.Italy Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 64.Italy Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 65.Italy Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 66.Italy Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 67.United Kingdom Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 68.United Kingdom Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 69.United Kingdom Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 70.United Kingdom Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 71.United Kingdom Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 72.United Kingdom Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 73.United Kingdom Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 74.Russia Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 75.Russia Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 76.Russia Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 77.Russia Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 78.Russia Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 79.Russia Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 80.Russia Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 81.Netherlands Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 82.Netherlands Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 83.Netherlands Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 84.Netherlands Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 85.Netherlands Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 86.Netherlands Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 87.Netherlands Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 88.Spain Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 89.Spain Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 90.Spain Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 91.Spain Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 92.Spain Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 93.Spain Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 94.Spain Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 95.Turkey Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 96.Turkey Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 97.Turkey Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 98.Turkey Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 99.Turkey Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 100.Turkey Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 101.Turkey Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 102.Poland Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 103.Poland Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 104.Poland Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 105.Poland Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 106.Poland Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 107.Poland Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 108.Poland Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 109.South America Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 110.South America Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 111.South America Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 112.South America Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 113.South America Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 114.South America Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 115.South America Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 116.South America Needle Free Injections System Market Share (%), By Country, 2017-2031F
• Figure 117.Brazil Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 118.Brazil Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 119.Brazil Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 120.Brazil Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 121.Brazil Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 122.Brazil Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 123.Brazil Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 124.Argentina Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 125.Argentina Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 126.Argentina Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 127.Argentina Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 128.Argentina Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 129.Argentina Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 130.Argentina Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 131.Asia-Pacific Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 132.Asia-Pacific Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 133.Asia-Pacific Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 134.Asia-Pacific Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 135.Asia-Pacific Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 136.Asia-Pacific Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 137.Asia- Pacific Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 138.Asia-Pacific Needle Free Injections System Market Share (%), By Country, 2017-2031F
• Figure 139.India Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 140.India Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 141.India Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 142.India Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 143.India Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 144.India Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 145.India Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 146.China Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 147.China Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 148.China Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 149.China Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 150.China Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 151.China Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 152.China Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 153.Japan Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 154.Japan Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 155.Japan Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 156.Japan Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 157.Japan Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 158.Japan Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 159.Japan Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 160.Australia Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 161.Australia Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 162.Australia Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 163.Australia Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 164.Australia Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 165.Australia Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 166.Australia Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 167.Vietnam Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 168.Vietnam Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 169.Vietnam Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 170.Vietnam Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 171.Vietnam Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 172.Vietnam Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 173.Vietnam Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 174.South Korea Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 175.South Korea Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 176.South Korea Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 177.South Korea Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 178.South Korea Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 179.South Korea Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 180.South Korea Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 181.Indonesia Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 182.Indonesia Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 183.Indonesia Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 184.Indonesia Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 185.Indonesia Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 186.Indonesia Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 187.Indonesia Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 188.Philippines Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 189.Philippines Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 190.Philippines Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 191.Philippines Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 192.Philippines Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 193.Philippines Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 194.Philippines Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 195.Middle East & Africa Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 196.Middle East & Africa Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 197.Middle East & Africa Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 198.Middle East & Africa Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 199.Middle East & Africa Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 200.Middle East & Africa Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 201.Middle East & Africa Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 202.Middle East & Africa Needle Free Injections System Market Share (%), By Country, 2017-2031F
• Figure 203.Saudi Arabia Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 204.Saudi Arabia Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 205.Saudi Arabia Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 206.Saudi Arabia Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 207.Saudi Arabia Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 208.Saudi Arabia Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 209.Saudi Arabia Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 210.UAE Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 211.UAE Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 212.UAE Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 213.UAE Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 214.UAE Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 215.UAE Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 216.UAE Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 217.South Africa Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
• Figure 218.South Africa Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
• Figure 219.South Africa Needle Free Injections System Market Share (%), By Products, 2017-2031F
• Figure 220.South Africa Needle Free Injections System Market Share (%), By Technology, 2017-2031F
• Figure 221.South Africa Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
• Figure 222.South Africa Needle Free Injections System Market Share (%), By Application, 2017-2031F
• Figure 223.South Africa Needle Free Injections System Market Share (%), By End-user, 2017-2031F
• Figure 224.By Products Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 225.By Technology Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 226.By Site of Delivery Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 227.By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 228.By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 229.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

The global needle free injection system market is projected to witness a CAGR of 15.1% during the forecast period 2024-2031, growing from USD 150.86 million in 2023 to USD 464.7 million in 2031. The global needle free injection system is being driven by factors such as the increasing preference of patients towards self-administration, rising hospitalization rates, clinical advantages offered by needle free injection systems as compared to conventional needles, technological advancements, increasing prevalence of chronic diseases, and growing emphasis towards patient safety and comfort. Needle free injectors, also known as jet injectors, are medical devices that deliver medication through the skin by using high pressure stream of fluid without the need for a needle. The main purpose of developing needle free injection system was to reduce needlestick injuries, cross-contamination, and needle reuse. Needle-free injectors have evolved over the years and are being recommended by the World Health Organization to address polio vaccine supply shortages. Needle free injectors are ideal for personal use to self-administer insulin, hormones, vitamin B-12, and other liquid injectable grade medications.

Microneedles are becoming more and more popular because of their ability to enter the human body and skin effectively without causing drug degradation. Their easy-to-operate microscale form factor and painless drug delivery are additional factors driving their demand among the general population.

In June 2023, PharmaJet announced that two new COVID-19 vaccines would only be administered intradermally using its Tropis system. The precision delivery systems developed by PharmaJet, based in Golden, Colorado, solve the problems associated with the delivery of nucleic acid vaccines. The first plasmid DNA COVID-19 vaccine from Zydus Lifesciences can now be delivered using its Tropis system. According to PharmaJet, Tropis has already completed millions of injections as part of several global immunization campaigns. Data consistently showed that nucleic acid vaccines and treatments had higher immunogenicity than those administered by needle and syringe or electroporation.

Increasing Prevalence of Infectious Diseases and Diabetes

The increasing prevalence of diabetes and other infectious diseases is significantly driving the global needle free injection system market. The need for effective and patient-friendly drug or vaccine delivery methods is growing due to the increasing prevalence of diabetes and infectious diseases. By reducing the discomfort associated with infections, needle-free injectors present a convincing alternative that enhances patient adherence to treatment protocols. Needle free injections are becoming more and more popular due to the rise in chronic illnesses like diabetes and autoimmune diseases, which makes needle-free alternatives a painless choice. Additionally, the importance of needle-free technologies and solutions has become more widely recognized due to the increasing risk of transmission through needle-based injections. Since 2021, there has been a significant increase in different infectious diseases, such as TB, influenza, diphtheria, pneumonia, mumps, and malaria, accounting for 20.6%, 354.3%, 220.5%, 2656.1%, and 990.3%, respectively.

Increasing Preference of Patients Towards Self-Administration

Patient preferences for self-administration of medications have significantly changed with the introduction of novel needle-free injection systems. This trend arises from several factors that improve patients' overall wellbeing, safety, and convenience. By eliminating the possibility of needlestick injuries, needle-free injectors reduce the possible risks associated with using traditional needles. By providing painless drug delivery, they improve patient satisfaction and comfort during the administration of medications. Compared to invasive drug delivery systems, needle-free injectors allow for faster drug delivery, which improves bioavailability and efficacy. The need for accessible and user-friendly medication administration methods will grow as the world's population ages and the prevalence of chronic illnesses rises. Needle-free injectors have the potential to completely transform medicine administration, which will ultimately benefit patients and healthcare professionals by providing an effective solution to the problems associated with traditional needle injections.

According to estimates from the Centers for Disease Control and Prevention (CDC), more than 3,85,000 hospital-based workers face needlestick injuries annually. Similar injuries also happen in private homes, clinics, emergency rooms, and other healthcare settings. Sharp injuries have been linked to the transmission of over 20 different pathogens, but they are mainly linked to the transmission of hepatitis B, hepatitis C, and human immunodeficiency virus (HIV).

Technological Advancements

Needle free injectors are a groundbreaking advancement in the field of medical devices and drug/vaccine delivery systems. It offers a patient-friendly and efficient alternative to traditional needle-based injections. The most recent advancement in this field is increasing focus on enhancing dosage control, reducing discomfort, and increasing accuracy. One noteworthy advancement is the use of liquid streams accelerated to high velocities to pierce the skin in place of traditional needles. Personalized healthcare has improved with the advent of smart needle-free injectors that are outfitted with cutting-edge sensors and connectivity features to facilitate real-time monitoring and data collection.

In January 2023, the FDA approved the DropSafe Sicura passive safety needle, an innovative injection needle with a fully passive mechanism that can be used for the intramuscular and subcutaneous injection of vaccines and other drugs, according to a press release from MTD Group's affiliate Pikdare S.p.A. A transparent shield guards the needle and locks automatically after injection, eliminating the need for the healthcare professionals to perform a post-injection incremental activation step.

North America Holds the Largest Share in the Market

North America accounts for more than 50% of the global needle free infection system market. North America's dominance can be attributed to several factors such as the presence of major players, innovative technologies, and a fast regulatory process by the FDA. The region offers a strong healthcare infrastructure and a high degree of awareness about the advantages of needle-free injection technologies among the public and healthcare professionals. In North America, the prevalence of diabetes and infectious diseases is comparatively high, which generates a significant demand for advanced drug delivery systems. Significant market players have a strong presence in the USA, Canada, Mexico, and global markets. The regulatory framework is favorable, encouraging innovation and the adoption of new medical technologies. The United States has a hassle-free approval and commercialization process for needle-free injection systems due to the FDA's support.

In June 2022, Berkeley-based NovaXS Biotech Corporation, a medical device company, unveiled its smart, needle-free drug delivery device. With its patent-pending Telosis technology, NovaXS will be able to analyze injection data and provide a precise, needle-free medication stream in just 0.3 seconds, enabling more informed health decisions. In a press release, the company stated that its technology is the first of its kind in the world for remote medication delivery and self-administration monitoring, providing a simple and painless substitute.

Fillable Needle Free Injectors Hold the Largest Share Globally

Fillable injectors account for the largest share of the global needle free injection system market. Fillable needle-free injectors offer several advantages over prefilled needle-free injectors. One key advantage is the ability to customize dosages by allowing on-demand filling of the injector device with the desired medication, providing flexibility in drug administration. Fillable injectors also offer the potential for targeted drug delivery, ensuring precise dosages tailored to individual patient needs. Additionally, fillable injectors can accommodate a variety of medications, making them versatile for different treatment regimens. In contrast, prefilled injectors come pre-loaded with a specific dosage, limiting the flexibility in drug administration and customization compared to fillable injectors. Moreover, fillable injectors can be more cost-effective as they allow for the use of generic medications or multiple doses from a single vial, reducing overall treatment costs.

Future Market Scenario (2024-2031F)

The future market scenario for the global needle free injection system market is poised for substantial growth, driven by new technologies. There is an increasing demand for painless drug delivery methods, leading to the adoption of needle-free injectors as a patient-friendly alternative. Advancements in microfluidics and nanotechnology have paved the way for more precise and efficient drug administration. Integration of smart features, such as connectivity with phones and personalized dosing, is becoming a prominent trend. The market is also witnessing the development of wearable injectors that offer convenience and continuous monitoring. Microjet and spring jets are gaining popularity for their effectiveness and reduced discomfort.

Key Players Landscape and Outlook

The global needle free injection system market is characterized by a competitive landscape with key players driving innovation and market expansion. The global market is dominated by players such as Pharmajet Inc., Crossject SA, Medical International Technology Inc., Micropoint Technologies Pte Ltd, Antres Pharma Inc., Penjet Corporation, NuGen Medical Devices Inc., Ferring International Center SA, Portal Instruments Inc., and Bioject Medical Technologies Inc. These market players are investing in R&D to improve product efficacy, patient comfort and dosage precision. Partnerships and collaborations between medical device and pharmaceutical companies for the integration of needle free injection systems with specific medications are becoming common, further strengthening the presence of these market players.

In May 2022, the world's first disposable range of needle-free livestock vaccination devices was launched by Pulse NeedleFree Systems, the top provider of needle-free delivery technologies to the animal health sector. As a fixed dose device, the Pulse FX doesn't need to have any parts replaced or maintenance done. Dosage volumes ranging from 0.2 ml to 2.0 ml are available, with options for stationery or hand-held delivery.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Needle Free Injection System Market Outlook, 2017-2031F

• 4.1.Market Size & Forecast
  • 4.1.1.By Value
  • 4.1.2.By Volume
• 4.2.By Products
  • 4.2.1.Fillable
  • 4.2.2.Prefilled
• 4.3.By Technology
  • 4.3.1.Spring Based Needle Free Injectors
  • 4.3.2.Gas Powered Needle Free Injectors
  • 4.3.3.Laser Powered Needle Free Injectors
  • 4.3.4.Vibration Based Needle Free Injectors
• 4.4.By Site of Delivery
  • 4.4.1.Intradermal
  • 4.4.2.Intramuscular
  • 4.4.3.Subcutaneous
• 4.5.By Application
  • 4.5.1.Vaccine Delivery
  • 4.5.2.Insulin Delivery
  • 4.5.3.Pain Management
  • 4.5.4.Others
• 4.6.By End-user
  • 4.6.1.Hospitals & Clinics
  • 4.6.2.Home Care Settings
  • 4.6.3.Ambulatory Surgical Centers
  • 4.6.4.Others
• 4.7.By Region
  • 4.7.1.North America
  • 4.7.2.Europe
  • 4.7.3.Asia-Pacific
  • 4.7.4.South America
  • 4.7.5.Middle East and Africa
• 4.8.By Company Market Share (%), 2023

5.Global Needle Free Injection System Market Outlook, By Region, 2017-2031F

• 5.1.North America*
  • 5.1.1.Market Size & Forecast
    • 5.1.1.1.By Value
    • 5.1.1.2.By Volume
  • 5.1.2.By Products
    • 5.1.2.1.Fillable
    • 5.1.2.2.Prefilled
  • 5.1.3.By Technology
    • 5.1.3.1.Spring Based Needle Free Injectors
    • 5.1.3.2.Gas Powered Needle Free Injectors
    • 5.1.3.3.Laser Powered Needle Free Injectors
    • 5.1.3.4.Vibration Based Needle Free Injectors
  • 5.1.4.By Site of Delivery
    • 5.1.4.1.Intradermal
    • 5.1.4.2.Intramuscular
    • 5.1.4.3.Subcutaneous
  • 5.1.5.By Application
    • 5.1.5.1.Vaccine Delivery
    • 5.1.5.2.Insulin Delivery
    • 5.1.5.3.Pain Management
    • 5.1.5.4.Others
  • 5.1.6.By End-user
    • 5.1.6.1.Hospitals & Clinics
    • 5.1.6.2.Home Care Settings
    • 5.1.6.3.Ambulatory Surgical Centers
    • 5.1.6.4.Others
  • 5.1.7.United States*
    • 5.1.7.1.Market Size & Forecast
    • 5.1.7.1.1.By Value
    • 5.1.7.1.2.By Volume
    • 5.1.7.2.By Products
    • 5.1.7.2.1.Fillable
    • 5.1.7.2.2.Prefilled
    • 5.1.7.3.By Technology
    • 5.1.7.3.1.Spring Based Needle Free Injectors
    • 5.1.7.3.2.Gas Powered Needle Free Injectors
    • 5.1.7.3.3.Laser Powered Needle Free Injectors
    • 5.1.7.3.4.Vibration Based Needle Free Injectors
    • 5.1.7.4.By Site of Delivery
    • 5.1.7.4.1.Intradermal
    • 5.1.7.4.2.Intramuscular
    • 5.1.7.4.3.Subcutaneous
    • 5.1.7.5.By Application
    • 5.1.7.5.1.Vaccine Delivery
    • 5.1.7.5.2.Insulin Delivery
    • 5.1.7.5.3.Pain Management
    • 5.1.7.5.4.Others
    • 5.1.7.6.By End-user
    • 5.1.7.6.1.Hospitals & Clinics
    • 5.1.7.6.2.Home Care Settings
    • 5.1.7.6.3.Ambulatory Surgical Centers
    • 5.1.7.6.4.Others
  • 5.1.8.Canada
  • 5.1.9.Mexico

All segments will be provided for all regions and countries covered

• 5.2.Europe
  • 5.2.1.Germany
  • 5.2.2.France
  • 5.2.3.Italy
  • 5.2.4.United Kingdom
  • 5.2.5.Russia
  • 5.2.6.Netherlands
  • 5.2.7.Spain
  • 5.2.8.Turkey
  • 5.2.9.Poland
• 5.3.Asia-Pacific
  • 5.3.1.India
  • 5.3.2.China
  • 5.3.3.Japan
  • 5.3.4.Australia
  • 5.3.5.Vietnam
  • 5.3.6.South Korea
  • 5.3.7.Indonesia
  • 5.3.8.Philippines
• 5.4.South America
  • 5.4.1.Brazil
  • 5.4.2.Argentina
• 5.5.Middle East & Africa
  • 5.5.1.Saudi Arabia
  • 5.5.2.UAE
  • 5.5.3.South Africa

6.Market Mapping, 2023

• 6.1.By Products
• 6.2.By Technology
• 6.3.By Site of Delivery
• 6.4.By Application
• 6.5.By End-user
• 6.6.By Region

7.Macro Environment and Industry Structure

• 7.1.Demand Supply Analysis
• 7.2.Import Export Analysis
• 7.3.Value Chain Analysis
• 7.4.PESTEL Analysis
  • 7.4.1.Political Factors
  • 7.4.2.Economic System
  • 7.4.3.Social Implications
  • 7.4.4.Technological Advancements
  • 7.4.5.Environmental Impacts
  • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5.Porter's Five Forces Analysis
  • 7.5.1.Supplier Power
  • 7.5.2.Buyer Power
  • 7.5.3.Substitution Threat
  • 7.5.4.Threat from New Entrant
  • 7.5.5.Competitive Rivalry

8.Market Dynamics

• 8.1.Growth Drivers
• 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

• 9.1.Clinical Trials
• 9.2.Patent Landscape
• 9.3.Regulatory Approvals
• 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

• 10.1.Competition Matrix of Top Five Market Leaders
• 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4.SWOT Analysis (For Five Market Players)
• 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

• 13.1.Pharmajet Inc
  • 13.1.1.Company Details
  • 13.1.2.Key Management Personnel
  • 13.1.3.Products & Services
  • 13.1.4.Financials (As reported)
  • 13.1.5.Key Market Focus & Geographical Presence
  • 13.1.6.Recent Developments
• 13.2.Crossject SA
• 13.3.Medical International Technology Inc
• 13.4.Micropoint Technologies Pte Ltd
• 13.5.Antres Pharma Inc
• 13.6.Penjet Corporation
• 13.7.NuGen Medical Devices Inc
• 13.8.Ferring International Center SA
• 13.9.Portal Instruments Inc
• 13.10.Bioject Medical Technologies Inc

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer